Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case–control study on survival in patients with two year follow-up
Authors:
- Anna FagottiAFAnna Fagotti
- Barbara CostantiniBCBarbara Costantini
- Marco PetrilloMPMarco Petrillo
- Giuseppe VizzielliGiuseppe Vizzielli
- Francesco FanfaniFFFrancesco Fanfani
- Pasquale Alessandro MargaritiPMPasquale Alessandro Margariti
- Luigi Carlo TurcoLTLuigi Carlo Turco
- Elisa PiovanoEPElisa Piovano
- Giovanni ScambiaGSGiovanni Scambia
- 1 December 2012
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 127 (3) , 502-505
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: Postoperative and long‐term resultsJournal of Surgical Oncology, 2012
- Heterogeneity in patients and methods. A problem for hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in ovarian carcinomaEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2011
- HIPEC in recurrent ovarian cancer patients: Morbidity-related treatment and long-term analysis of clinical outcomeGynecologic Oncology, 2011
- Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancerEuropean Journal of Surgical Oncology, 2011
- Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current resultsJournal of Cancer Research and Clinical Oncology, 2009
- Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: A pilot studyGynecologic Oncology, 2009
- Surgical Management of Recurrent Ovarian CancerSeminars in Oncology, 2009
- Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: Clinical considerationsEuropean Journal of Cancer, 2006
- Intraperitoneal Cisplatin and Paclitaxel in Ovarian CancerNew England Journal of Medicine, 2006
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976